Sharon Levy

Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus

Ayelet Grupper, Liane Rabinowich, Doron Schwartz et al. · American Journal of Transplantation · 2021 · 358 citations · Full text

Evaluation of the efficacy and tolerability of 0.5% fluorouracil cream and 5% fluorouracil cream applied to each side of the face in patients with actinic keratosis

Keith H. Loven, Linda Stein, Katharine Furst et al. · Clinical Therapeutics · 2002 · 168 citations

Ophthalmology, Actinic Keratosis, Clinical Dermatology +4

Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: Results of two placebo-controlled studies of daily application to the face and balding scalp for two 3-week cycles

C. William Hanke, Kenneth Beer, Eggert Stockfleth et al. · Journal of the American Academy of Dermatology · 2010 · 156 citations

Imiquimod 2.5, Ophthalmology, 3-Week Cycles +7

Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: Results of two placebo-controlled studies of daily application to the face and balding scalp for two 2-week cycles

Neil A. Swanson, William Abramovits, Brian Berman et al. · Journal of the American Academy of Dermatology · 2010 · 149 citations

Imiquimod 2.5, Ophthalmology, Placebo-controlled Studies +7

A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris

W.J. Cunliffe, Keith T. Holland, R.A. Bojar et al. · Clinical Therapeutics · 2002 · 110 citations

Medicine, Antibiotic Adjuvant, Acne Vulgaris +8